Building negative incentives into value-based insurance design programs to discourage use of low-value care will involve a number of challenges.
Dan Greenberg, PhD
Advertisement
Articles by Dan Greenberg, PhD
A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.
Advertisement
Latest Updated Articles
- Do Drug Formulary Policies Reflect Evidence of Value?
Published: January 1st 2006 | Updated:
- Low-Value Services in Value-Based Insurance Design
Published: April 7th 2010 | Updated:
- Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
Published: September 7th 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
3
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
4
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
5
